1
0
0
(1 - 13 von 14
)
OASIS
www.abstractsonline.com
CommercialRelationships: Volker Enzmann, NOXXON Pharma (F); Axel Vater, NOXXON Pharma (E); Sven Klussmann, NOXXON Pharma (E); Sebastian Wolf, ...
Effect of a calcitonin gene-related peptide-binding L-RNA ...BioMed Central
thejournalofheadacheandpain.biomedcentral.com
von MJM Fischer · · Zitiert von: 10 — Michael J. M. Fischer,; Jakob Schmidt,; Stanislav Koulchitsky,; Sven Klussmann,; Axel Vater & … Karl Messlinger. Show authors.
BibTeX-Output - IMISE Leipzigwww.imise.uni-leipzig.de › Institut › BibTeXoutput
www.imise.uni-leipzig.de
... and Kai Hoehlig and Sven Klussmann and Axel Vater and Theresa C. Firsching and Judith Hoppe and Norbert Suttorp and Martin Witzenrath}, year = {2020},
Structural basis for the targeting of complement anaphylatoxin ...
www.nature.com
von L Yatime · · Zitiert von: 73 — NOXXON Pharma AG, -10, BerlinGermany. Christian Maasch, Kai Hoehlig, Sven Klussmann & Axel Vater. Authors. › articles
C5a neutralization is protective in severe pneumonia ...www.researchsquare.com › article
www.researchsquare.com
... Scholz, Peter Ahnert, Christian Maasch, Kai Hoehlig, Sven Klussmann, Axel Vater, Theresa C. Firsching Judith Hoppe, Norbert Suttorp, Martin Witzenrath ...
Neutralizing Complement C5a Protects Mice with ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von H Müller-Redetzky · · Zitiert von: 18 — ... Peter Ahnert, Christian Maasch, Kai Hoehlig, Sven Klussmann, Axel Vater, Theresa C Firsching, Judith Hoppe, Norbert Suttorp, Martin Witzenrath ... von WG Purschke · · Zitiert von: 91 — Werner G. Purschke, Falko Radtke, Frank Kleinjung, and Sven Klussmann*. Author information Article notes Copyright and License information Disclaimer.
Targeting complement component 5a promotes vascular ...Europe PMC
europepmc.org
von MA Khan · · Zitiert von: 65 — Targeting complement component 5a promotes vascular integrity and limits airway remodeling. Mohammad A. Khan,a Christian Maasch,b Axel Vater,bSven Klussmann,b ...
OPUS FAU | Effect of a calcitonin gene-related peptide ...opus4.kobv.de › year › docId
opus4.kobv.de
Michael J. M. Fischer, Jakob Schmidt, Stanislav Koulchitsky, Sven Klussmann, Axel Vater, Karl Messlinger. Background Calcitonin gene-related ...
Aegean Conferences
www.aegeanconferences.org
Laure Yatime, Christian Maasch, Kai Hoehlig, Sven Klussmann, Axel Vater, and Gregers Rom Andersen Effects of the compstatin analog Cp40 and of the ...
Structural basis for the targeting of complement anaphylatoxin C5a...
pure.au.dk
author = "Laure Yatime and Christian Maasch and Kai Hoehlig and Sven Klussmann and Andersen, {Gregers Rom} and Axel Vater",. year = "2015",.
Turning mirror-image oligonucleotides into drugs
cyberleninka.org
Abstract of research paper on Chemical sciences, author of scientific article — Axel Vater, Sven Klussmann. Spiegelmers are synthetic target-binding ... › article
Structural basis for the targeting of complement anaphylatoxin C5a...
pure.au.dk
Laure Yatime, Denmark; Christian Maasch, Germany; Kai Hoehlig, Germany; Sven Klussmann, Germany; Gregers Rom Andersen; Axel Vater, Germany.
Turning mirror-image oligonucleotides into drugs PubMedpubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
2015 Jan;20(1): doi: j.drudis Epub Sep 16. Authors. Axel Vater , Sven Klussmann. Affiliations. 1 NOXXON Pharma AG, ...
Alle Infos zum Namen "Sven Klussmann"
sortiert nach Relevanz / Datum